Physical therapy program for cervical dystonia: A study of 20 cases

Functional Neurology

Volumn 27, Issue 3, 2012, Pages 187-192

  Queiroz, Mariana Araujo Ribeiro ^a   Chien, Hsin Fen ^a   Sekeff Sallem, Flávio Augusto ^a   Barbosa, Egberto Reis ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Botulinum toxin type A; Cervical dystonia; Physical therapy; Quality of life

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CERVICAL DYSTONIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; EXERCISE; FEMALE; FUNCTIONAL ELECTRICAL STIMULATION; GENERAL CONDITION IMPROVEMENT; HEALTH PROGRAM; HUMAN; KINESIOTHERAPY; MALE; MENTAL HEALTH; OPEN STUDY; PAIN; PHYSIOTHERAPY; SHORT FORM 36;

EID: 84873693824     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Camfield L, Ben-Shlomo Y, Warner TT; Epidemiological Study of Dystonia in Europe Collaborative Group. Impact of cervical dystonia in quality of life. Mov Disord 2002; 17: 838-841.
2. Tarsy D, Simon DK. Dystonia. N Eng J Med 2006; 355: 818-829.
3. Bogey RA, Elovic EP, Bryant PR, Geis CC, Moroz A, O'Neill BJ. Rehabilitation of movement disorders. Arch Phys Med Rehabil 2004; 85 Suppl 1: S41-S45.
4. Ramdharry G. Case report: physiotherapy cuts the dose of botulinum toxin. Physiother Res Int 2006; 11:117-122.
5. Smania M, Corato E, Tinazzi M, Montagnana B, Fiaschi A, Aglioti SM. The effect of two different rehabilitation treatments in cervical dystonia: preliminary results in four patients. Funct Neurol 2003; 18: 219-225.
6. Tassorelli C, Mancini F, Balloni L et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord 2006; 21: 2240-2243.
7. Zetterberg L, Halvorsen K, Farnstrand C, Aquilonius SM, Lindmark B. Physiotherapy in cervical dystonia: six experimental single cases studies. Physiother Theory Pract 2008; 24: 275-290.
8. Karnath HO, Konczac J, Dichgans J. Effect of prolonged neck muscle vibration on lateral head tilt in severe spasmodic torticollis. J Neurol Neurosurg Psychiatry 2000; 69: 658-660.
9. Maia FM, Kanashiro AK, Chien HF, Goncalves LR, Barbosa ER. Clinical changes in cervical dystonia pattern in long-term botulinum toxin treated patients. Parkinsonism Relat Disord 2010; 16:8-11.
10. Severo M, Santos AC, Lopes C, Barros H. [Reliability and validity in measuring physical and mental health construct of the Portuguese version of MOS SF-36]. Acta Med Port 2006; 19: 281-287.
11. Ciconelli R M, Ferraz M B, Santos W, Meinao I, Marina R Q Traducao para a lingua portuguesa e validacao do questionario generico de avaliacao de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol 1999; 39: 143-150.
12. Consky E, Basinkmi A, Bellem L, Ranawayam R, Lang A. The Toronto Western Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 1990; 40: 445 [abstract].
13. Sekeff-Sallem FA, Caramelli P, Barbosa ER. Cross-cultural adaptation of Toronto Western Spasmodic Torticollis Ratong Scale (TWSTRS) to Brazilian Portuguese. Arq Neuropsiquiatr 2011; 69: 316-319.
14. Truong D, Duane DD, Jankovic J et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebocontrolled study. Mov Disord 2005; 20: 783-791.
15. Gudex CM, Hawthorne MR, Butler AG, Duffey P. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord 1998; 13: 941-946.
16. Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993;43: 834-836.
17. Buccolieri A, Avanzino L, Marinelli L, Trompetto C, Marchese R, Abbruzzese G. Muscle relaxation is impaired in dystonia: a reaction time study. Mov Disord 2004; 19: 681-687.
18. Hauptmann B, Karni A. From primed to learn: the saturation of repetition priming and the induction of long-term memory. Brain Res Cogn Brain Res 2002; 13: 313-322.
19. Hakkinen A, Ylinen J, Rinta-Keturi M, Talvitie U, Kautiainen H, Rissanen A. Decreased neck muscle strength is highly ssociated with pain in cervical dystonia patients treated with botulinum toxin injections. Arch Phys Med Rehabil 2004; 85:1684-1688.
20. Daly JJ, Roenigk K, Holcomb J et al. A randomized controlled trial of functional neuromuscular stimulation in chronic stroke subjects. Stroke 2006; 37: 172-178.
21. Page D, Butler A, Jahanshahi M. Quality of life in focal, segmental, and generalized dystonia. Mov Disord 2007; 22: 341-347.
22. Skogseid IM, Malt UF, Roislien J, Kerty I. Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia. Eur J Neurol 2007; 14: 1129-1137.
23. Slawek J, Friedman A, Potulska A et al. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol 2007; 22: 95-100.
24. Queiroz MR, Chien HF, Barbosa ER. Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital. Arq Neuropsquiatr 2011; 69: 900-904.
25. Muller J, Kemmler G, Wissel J et al.; Austrian Botulinum Toxin and Dystonia Study Group. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 2002; 249: 842-846.